Previous studies have shown that overexpression of ZNRF2 promotes cancer cell growth and inhibits cancer cell apoptosis in NSCLC1616 and osteosarcoma44, which is consistent with the findings in liver cancer cells (HepG2) (Figure 9E–G). Here, ZNRF2 is linked to liver cancer.